Adeno-Associated Virus Type 5 Infection via PDGFRα Is Associated With Interstitial Lung Disease in Systemic Sclerosis

Gianluca Moroncini1, Silvia Svegliati2, Antonella Grieco2

  • 1Università Politecnica delle Marche and Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy.

Abstract

Insights

This study found adeno-associated virus type 5 (AAV5) in systemic sclerosis (SSc) lungs, forming a complex with platelet-derived growth factor receptor alpha (PDGFRα). This complex may trigger immune responses, offering a new insight into SSc pathogenesis.

Area of Science:

  • Immunology
  • Virology
  • Pulmonology

Background:

  • Systemic sclerosis (SSc) pathogenesis remains unknown.
  • Platelet-derived growth factor receptors (PDGFRs) are overexpressed in SSc patients.
  • PDGFRα is a target of adeno-associated virus type 5 (AAV5).

Purpose of the Study:

  • To investigate if AAV5 forms a complex with PDGFRα.
  • To determine if this complex exposes epitopes that induce immune responses in SSc.

Main Methods:

  • In silico molecular docking and surface plasmon resonance (SPR) analyzed PDGFRα-AAV5 binding.
  • AAV5 presence in SSc lungs was assessed using in situ hybridization and immunohistochemistry.
  • Immune responses were evaluated using SSc patient antibodies and SPR.

Main Results:

  • AAV5 was detected in the bronchoalveolar lavage (BAL) fluid of 62.1% of SSc patients versus 25.75% of controls.
  • A molecular complex of AAV5 and PDGFRα with spatially contiguous epitopes was identified.
  • SSc patient antibodies recognized epitopes from both PDGFRα and AAV5 within the complex.

Conclusions:

  • AAV5 is linked to immune reactivity against endogenous antigens in SSc.
  • The AAV5-PDGFRα complex represents a novel factor in SSc pathogenesis.